P01008 (ANT3_HUMAN) Homo sapiens (Human)

Antithrombin-III UniProtKBInterProSTRINGInteractive Modelling

464 aa; Sequence (Fasta)

Available Structures

27 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
Crystal structure of the antithrombin-factor IXa-pentasaccharide complex Heteromer
P00740;
35-463
99.76NAG;NAG;Z9L;CA;MPD;
2.5A Crystal Structure of the Antithrombin-Thrombin-Heparin Ternary Complex Heteromer
P00734;
36-463
99.27NAG;GU3;NAG;NAG;MPD;NAG;
ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE Heteromer
P00734;
37-463
100.0YYB;NAG;GU4;
Crystal Structure of the Antithrombin-S195A Factor Xa-Pentasaccharide Complex Heteromer
P00742;
37-463
99.04NAG;ZDO;CA;NAG;
2.1 Angstrom structure of a nonproductive complex between antithrombin, synthetic heparin mimetic S… Heteromer
P00734;
38-463
99.28NAG;GU3;NAG;NAG; 12×GOL;SO4;NAG;
Crystal Structure of a Domain-Swapped Serpin Dimerhomo-2-mer33-463
100.0NAG;NAG;NAG;CIT;
Crystal structure of antithrombin variant S137A/V317C/T401C with plasma latent antithrombinhomo-2-mer36-463
99.27NAG;NAG;NAG;GOL;
Crystal structure at 2.6A of the ternary complex between antithrombin, a P14-P8 reactive loop pepti…homo-2-mer37-463
100.0NDG;NAG;
Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tr…homo-2-mer37-463
100.0NAG;GOL;FOR;
Crystal Structure of Antithrombin-IIIhomo-2-mer37-463
99.76NAG;NAG;
Structure of dimeric antithrombin complexed with a P14-P9 reactive loop peptide and an exogenous tr…homo-2-mer37-463
100.0NDG;NAG;GOL;
Intermediate structure of antithrombin bound to the natural pentasaccharidehomo-2-mer37-463
100.0NAG;NAG;NAG;ZDO;NAG;
THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONShomo-2-mer39-463
100.0
BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBINhomo-2-mer45-464
100.0
Crystal Structure of Native Antithrombin in its Monomeric Formmonomer34-464
99.28NAG;NAG;IOD;GOL;
PLASMA ALPHA ANTITHROMBIN-IIImonomer35-464
100.0NAG;NAG;PO4;NAG;MAN;GOL;
Hyperstable in-frame insertion variant of antithrombinmonomer37-464
99.45NAG;NAG;
PLASMA BETA ANTITHROMBIN-IIImonomer37-463
100.0NAG;NAG;MAN;GOL;
Crystal Structure of P13 Alanine Variant of Antithrombinmonomer37-463
99.52NAG;NAG;
Crystal Structure of P14 Alanine Variant of Antithrombinmonomer37-463
99.51NAG;NAG;NAG;GOL;
PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDEmonomer37-463
100.0NAG;Z9L;NAG;
ANTITHROMBIN/PENTASACCHARIDE COMPLEXmonomer37-463
100.0Z9L;NAG;
THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITEmonomer39-464
100.0NAA;
Crystal Structure of Antithrombin in the Pentasaccharide-Bound Intermediate Statemonomer38-463
100.0NAG;Z9L;NAG;
N135Q-S380C-ANTITHROMBIN-IIImonomer39-462
100.0NAG;NAG;GOL;
P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-IIImonomer39-462
100.0NAG;NAG;NAG;GOL;
IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBINmonomer40-463
100.0

2 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1jvq.1.Bmonomer0.8037-463
ACE;TRP;NAG;100.00
1oyh.2.Amonomer0.8037-462
NAG;100.00